Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimcan M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Medlex Biotechnics Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimcan M 2mg/500mg Tablet SR

DiaGlycem SR tablets (2mg/500mg) are antidiabetic medications combining two agents to manage type 2 diabetes in adults. This dual-action formulation regulates blood glucose. DiaGlycem SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including kidney impairment, vision loss, neuropathy, and limb amputation. DiaGlycem SR is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as recommended by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Maintain regular eating intervals and carry a readily available fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. DiaGlycem SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before initiating treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Glimcan M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimcan M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimcan M 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with a meal.

Common Side effects of Glimcan M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimcan M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Glimcan M 2mg/500mg Extended-Release tablets with food.

How Glimcan M 2mg/500mg Tablet SR works:

Glimcan M 2mg/500mg extended-release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimcan M 2mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimcan M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimcan M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimcan M 2mg/500mg SR tablets, as dose modification may be necessary. Consult your physician for guidance. Glimcan M 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimcan M 2mg/500mg SR tablets cautiously, as dose modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimcan M 2mg/500mg Tablet SR :

Should you forget to take your Glimcan M 2mg/500mg SR Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimcan M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimcan M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimcan M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimcan M 2mg/500mg Tablet SR and seek immediate medical attention.
Glimcan M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimcan M 2mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimcan M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). Preventive measures may include annual supplemental vitamin B12 intake.
Glimcan M 2mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimcan M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol can further reduce blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimcan M 2mg/500mg Table...
53
MRP 65
18% off